The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs
The ASCO conference closed Tuesday, although presentations at the conference triggered some huge stocks moves. read more.....»»

The Week Ahead In Biotech: Conferences, Clinical Trials, Earnings And IPOs
The earnings season hasn't panned out well for pharma companies, with Amgen, Inc. (NASDAQ: AMGN), Novartis AG (NYS.....»»
The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs
The ASCO conference closed Tuesday, although presentations at the conference triggered some huge stocks moves. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Biotech stocks held steady in the recent week as earnings from the sector continue to trickle in. The week also saw presentations of clinical t.....»»
The Week Ahead In Biotech: Conferences, Clinical Trials
The new year kick started with a bumper deal in the pharma space, with Bristol-Myers Squibb Co (NYSE: BMY) agreeing to buy Celgene Corporation (NASDAQ: read more.....»»
The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings
Biotech stocks pulled back in last week. Incidentally, some large-cap biotec.....»»
The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings
Biotech stocks pulled back in last week. Incidentally, some large-cap .....»»
The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs
Large-cap pharma stocks are seeing some upward momentum and are on track to f.....»»
The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs
Large-cap pharma stocks are seeing some upward momentum and are on track to finish the year with handsome gains. As the year draws to a close, it remains to be see.....»»
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. With the earnin.....»»
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. read more.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs
As we step into the final quarter of 2018, biotech stocks have recorded double-digit gains for the year-to-date period. Will the run up continue? Stay tuned to the following events of the upcoming week. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs
After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs
After ending almost flat in the week ended Sept. 14, biotech stocks have seen.....»»
The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs
After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»
The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs
After ending almost flat in the week ended Sept. 14, .....»»
The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Biotech were trending mostly sideways in the week ending Sept. 14 after posting weekly gains in the previous two weeks. Notwithstanding the overall muted sentiment, there was some activity in reaction to the release of clinical trial results. read more.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs
After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month in the green, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) saw a moderation in momentum in the holiday-shortened week ending Sept. 7. read more.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs
After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month .....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
The biotech sector notched strong gains last week, capitalizing on the positive overall mark.....»»